Myopia Low-dose atropine shows greatest benefit in younger children with progressive myopia in Phase 3 STAR trial
Practice Management Online eye triage tool demonstrates accuracy and high patient acceptability in real-world study
Ocular Surface Disease Review highlights variability in dry eye disease rates among immune checkpoint inhibitor users
Ocular Surface Disease Switching to cyclosporine ophthalmic solution 0.09% improves signs and symptoms in patients with DED
Myopia Repeated low-level red light shows greater 12-month efficacy than 1% atropine in myopia control trial